0:22ABC NewsFebruary 23, 2023Pfizer’s RSV vaccine could get FDA approval by summerPfizer says its vaccine is 82% effective at preventing severe RSV infections in an infant’s first 90 days and 70% effective during the first six months.Up Next in newsNew York City to end COVID vaccine mandate for city workersFebruary 6, 2023Biden administration will end COVID-19 emergencies on May 11 January 31, 2023The 2024 total eclipse seen across North AmericaApril 8, 2024